4.7 Article

A Culture-Independent Sequence-Based Metagenomics Approach to the Investigation of an Outbreak of Shiga-Toxigenic Escherichia coli O104:H4

期刊

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
卷 309, 期 14, 页码 1502-1510

出版社

AMER MEDICAL ASSOC
DOI: 10.1001/jama.2013.3231

关键词

-

资金

  1. Novartis
  2. Gilead
  3. Germany by the Medical Faculty of the University Medical Center Hamburg-Eppendorf
  4. UK's Biotechnology and Biological Sciences Research Council
  5. UK's National Institute for Health Research
  6. MRC Special Training Fellowship in Biomedical Informatics
  7. Illumina Inc.
  8. BBSRC [BB/E011179/1] Funding Source: UKRI
  9. EPSRC [EP/H003851/1] Funding Source: UKRI
  10. MRC [MR/J014370/1, G0901717] Funding Source: UKRI
  11. Biotechnology and Biological Sciences Research Council [BB/E011179/1] Funding Source: researchfish
  12. Engineering and Physical Sciences Research Council [EP/H003851/1] Funding Source: researchfish
  13. Medical Research Council [MR/J014370/1, G0901717] Funding Source: researchfish

向作者/读者索取更多资源

Importance Identification of the bacterium responsible for an outbreak can aid in disease management. However, traditional culture-based diagnosis can be difficult, particularly if no specific diagnostic test is available for an outbreak strain. Objective To explore the potential of metagenomics, which is the direct sequencing of DNA extracted from microbiologically complex samples, as an open-ended clinical discovery platform capable of identifying and characterizing bacterial strains from an outbreak without laboratory culture. Design, Setting, and Patients In a retrospective investigation, 45 samples were selected from fecal specimens obtained from patients with diarrhea during the 2011 outbreak of Shiga-toxigenic Escherichia coli (STEC) O104:H4 in Germany. Samples were subjected to high-throughput sequencing (August-September 2012), followed by a 3-phase analysis (November 2012-February 2013). In phase 1, a de novo assembly approach was developed to obtain a draft genome of the outbreak strain. In phase 2, the depth of coverage of the outbreak strain genome was determined in each sample. In phase 3, sequences from each sample were compared with sequences from known bacteria to identify pathogens other than the outbreak strain. Main Outcomes and Measures The recovery of genome sequence data for the purposes of identification and characterization of the outbreak strain and other pathogens from fecal samples. Results During phase 1, a draft genome of the STEC outbreak strain was obtained. During phase 2, the outbreak strain genome was recovered from 10 samples at greater than 10-fold coverage and from 26 samples at greater than 1-fold coverage. Sequences from the Shiga-toxin genes were detected in 27 of 40 STEC-positive samples (67%). In phase 3, sequences from Clostridium difficile, Campylobacter jejuni, Campylobacter concisus, and Salmonella enterica were recovered. Conclusions and Relevance These results suggest the potential of metagenomics as a culture-independent approach for the identification of bacterial pathogens during an outbreak of diarrheal disease. Challenges include improving diagnostic sensitivity, speeding up and simplifying workflows, and reducing costs. JAMA. 2013;309(14):1502-1510 www.jama.com

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据